In human prostate cell lines, NCAPD3 was also higher in all tumor cell lines (PC‐3, DU145, 22Rv1, and LNCaP) than in non‐cancer cell lines (WPMY‐1 and BPH‐1) (Figure 1E). This evidence concerns the gene NCAPD3 and cancer.